Patients’ characteristics (N = 35).
| Characteristic | Value |
|---|---|
| Female, % | 77 (27/35) |
| Age, yrs, median (range) | 62 (30–80) |
| Diagnosis, n | |
| Systemic lupus erythematosus | 12 |
| Vasculitis syndrome | 12 |
| Rheumatoid arthritis | 5 |
| Polymyositis/dermatomyositis | 2 |
| Idiopathic thrombocytopenic purpura | 2 |
| Adult-onset Still’s disease | 1 |
| Autoimmune hemolytic anemia | 1 |
| Prednisolone, mg/day, median (range) | 60 (0–60) |
| Steroid pulse therapy, % | 60 (21/35) |
| Immunosuppressant, % | 60 (21/35) |
| Cyclophosphamide | 13 |
| Tacrolimus | 4 |
| Cyclophosphamide + tacrolimus | 2 |
| Methotrexate | 1 |
| Cyclosporin A | 1 |
| Biologics, % | 17 (6/35) |
| Rituximab | 3 |
| Infliximab | 1 |
| Etanercept | 1 |
| Tocilizumab | 1 |